Lineage Cell Therapeutics
LCTX
#8743
Rank
HK$0.92 B
Marketcap
HK$4.18
Share price
-1.91%
Change (1 day)
-52.23%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Total debt

Total debt on the balance sheet as of September 2024 : HK$21.35 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's total debt is HK$21.35 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Lineage Cell Therapeutics - Total debt on balance sheet (from 2001 to 2024)

Total debt by year

Year Total debt Change
2023-12-31HK$23.05 M-24.26%
2022-12-31HK$30.44 M39.33%
2021-12-31HK$21.84 M-26.33%
2020-12-31HK$29.65 M-26.32%
2019-12-31HK$40.25 M126.95%
2018-12-31HK$17.73 M48.08%
2017-12-31HK$11.97 M-61.21%
2016-12-31HK$30.87 M-21.93%
2015-12-31HK$39.55 M867.29%
2014-12-31HK$4.08 M
2013-12-31N/A
2008-12-31HK$14.61 M161.33%
2007-12-31HK$5.59 M
2003-12-31HK$20.84 M23.25%
2002-12-31HK$16.91 M25.31%
2001-12-31HK$13.49 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
HK$24.23 M 13.49%๐Ÿ‡บ๐Ÿ‡ธ USA